Literature DB >> 26649820

A mechanism for the suppression of homologous recombination in G1 cells.

Alexandre Orthwein1, Sylvie M Noordermeer1, Marcus D Wilson1, Sébastien Landry1, Radoslav I Enchev2, Alana Sherker1,3, Meagan Munro1, Jordan Pinder4, Jayme Salsman4, Graham Dellaire4, Bing Xia5, Matthias Peter2, Daniel Durocher1,3.   

Abstract

DNA repair by homologous recombination is highly suppressed in G1 cells to ensure that mitotic recombination occurs solely between sister chromatids. Although many homologous recombination factors are cell-cycle regulated, the identity of the events that are both necessary and sufficient to suppress recombination in G1 cells is unknown. Here we report that the cell cycle controls the interaction of BRCA1 with PALB2-BRCA2 to constrain BRCA2 function to the S/G2 phases in human cells. We found that the BRCA1-interaction site on PALB2 is targeted by an E3 ubiquitin ligase composed of KEAP1, a PALB2-interacting protein, in complex with cullin-3 (CUL3)-RBX1 (ref. 6). PALB2 ubiquitylation suppresses its interaction with BRCA1 and is counteracted by the deubiquitylase USP11, which is itself under cell cycle control. Restoration of the BRCA1-PALB2 interaction combined with the activation of DNA-end resection is sufficient to induce homologous recombination in G1, as measured by RAD51 recruitment, unscheduled DNA synthesis and a CRISPR-Cas9-based gene-targeting assay. We conclude that the mechanism prohibiting homologous recombination in G1 minimally consists of the suppression of DNA-end resection coupled with a multi-step block of the recruitment of BRCA2 to DNA damage sites that involves the inhibition of BRCA1-PALB2-BRCA2 complex assembly. We speculate that the ability to induce homologous recombination in G1 cells with defined factors could spur the development of gene-targeting applications in non-dividing cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26649820      PMCID: PMC4880051          DOI: 10.1038/nature16142

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  39 in total

1.  A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice.

Authors:  Cristina Escribano-Díaz; Alexandre Orthwein; Amélie Fradet-Turcotte; Mengtan Xing; Jordan T F Young; Ján Tkáč; Michael A Cook; Adam P Rosebrock; Meagan Munro; Marella D Canny; Dongyi Xu; Daniel Durocher
Journal:  Mol Cell       Date:  2013-01-17       Impact factor: 17.970

2.  RPA accumulation during class switch recombination represents 5'-3' DNA-end resection during the S-G2/M phase of the cell cycle.

Authors:  Arito Yamane; Davide F Robbiani; Wolfgang Resch; Anne Bothmer; Hirotaka Nakahashi; Thiago Oliveira; Philipp C Rommel; Eric J Brown; Andre Nussenzweig; Michel C Nussenzweig; Rafael Casellas
Journal:  Cell Rep       Date:  2013-01-03       Impact factor: 9.423

3.  MDC1 and RNF8 function in a pathway that directs BRCA1-dependent localization of PALB2 required for homologous recombination.

Authors:  Fan Zhang; Gregory Bick; Jung-Young Park; Paul R Andreassen
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

4.  RIF1 counteracts BRCA1-mediated end resection during DNA repair.

Authors:  Lin Feng; Ka-Wing Fong; Jiadong Wang; Wenqi Wang; Junjie Chen
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

Review 5.  Links between genome integrity and BRCA1 tumor suppression.

Authors:  Mischa L Li; Roger A Greenberg
Journal:  Trends Biochem Sci       Date:  2012-07-24       Impact factor: 13.807

Review 6.  The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications.

Authors:  Pascal Genschik; Izabela Sumara; Esther Lechner
Journal:  EMBO J       Date:  2013-08-02       Impact factor: 11.598

7.  53BP1 regulates DSB repair using Rif1 to control 5' end resection.

Authors:  Michal Zimmermann; Francisca Lottersberger; Sara B Buonomo; Agnel Sfeir; Titia de Lange
Journal:  Science       Date:  2013-01-10       Impact factor: 47.728

8.  RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection.

Authors:  J Ross Chapman; Patricia Barral; Jean-Baptiste Vannier; Valérie Borel; Martin Steger; Antonia Tomas-Loba; Alessandro A Sartori; Ian R Adams; Facundo D Batista; Simon J Boulton
Journal:  Mol Cell       Date:  2013-01-17       Impact factor: 17.970

9.  Acetylation limits 53BP1 association with damaged chromatin to promote homologous recombination.

Authors:  Jiangbo Tang; Nam Woo Cho; Gaofeng Cui; Erica M Manion; Niraj M Shanbhag; Maria Victoria Botuyan; Georges Mer; Roger A Greenberg
Journal:  Nat Struct Mol Biol       Date:  2013-02-03       Impact factor: 15.369

10.  53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark.

Authors:  Amélie Fradet-Turcotte; Marella D Canny; Cristina Escribano-Díaz; Alexandre Orthwein; Charles C Y Leung; Hao Huang; Marie-Claude Landry; Julianne Kitevski-LeBlanc; Sylvie M Noordermeer; Frank Sicheri; Daniel Durocher
Journal:  Nature       Date:  2013-06-12       Impact factor: 49.962

View more
  209 in total

1.  DNA repair: The cell cycle flavours of repair.

Authors:  Eytan Zlotorynski
Journal:  Nat Rev Mol Cell Biol       Date:  2015-12-23       Impact factor: 94.444

2.  DNA repair: The cell cycle flavours of repair.

Authors:  Eytan Zlotorynski
Journal:  Nat Rev Genet       Date:  2016-01-05       Impact factor: 53.242

Review 3.  Current Progress in Therapeutic Gene Editing for Monogenic Diseases.

Authors:  Versha Prakash; Marc Moore; Rafael J Yáñez-Muñoz
Journal:  Mol Ther       Date:  2016-01-14       Impact factor: 11.454

4.  Coupling of Homologous Recombination and the Checkpoint by ATR.

Authors:  Rémi Buisson; Joshi Niraj; Amélie Rodrigue; Chu Kwen Ho; Johannes Kreuzer; Tzeh Keong Foo; Emilie J-L Hardy; Graham Dellaire; Wilhelm Haas; Bing Xia; Jean-Yves Masson; Lee Zou
Journal:  Mol Cell       Date:  2017-01-12       Impact factor: 17.970

Review 5.  Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.

Authors:  Ling Li; Shuo Hu; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2018-04-18       Impact factor: 12.479

Review 6.  Pharmacological methods to transcriptionally modulate double-strand break DNA repair.

Authors:  Alanna R Kaplan; Peter M Glazer
Journal:  Int Rev Cell Mol Biol       Date:  2019-12-18       Impact factor: 6.813

7.  Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.

Authors:  Giovanni Germano; Simona Lamba; Giuseppe Rospo; Ludovic Barault; Alessandro Magrì; Federica Maione; Mariangela Russo; Giovanni Crisafulli; Alice Bartolini; Giulia Lerda; Giulia Siravegna; Benedetta Mussolin; Roberta Frapolli; Monica Montone; Federica Morano; Filippo de Braud; Nabil Amirouchene-Angelozzi; Silvia Marsoni; Maurizio D'Incalci; Armando Orlandi; Enrico Giraudo; Andrea Sartore-Bianchi; Salvatore Siena; Filippo Pietrantonio; Federica Di Nicolantonio; Alberto Bardelli
Journal:  Nature       Date:  2017-11-29       Impact factor: 49.962

8.  PCNA-Ub polyubiquitination inhibits cell proliferation and induces cell-cycle checkpoints.

Authors:  Zhoushuai Qin; Zhiqiang Bai; Ying Sun; Xiaohong Niu; Wei Xiao
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

9.  BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.

Authors:  Dali Zong; Salomé Adam; Yifan Wang; Hiroyuki Sasanuma; Elsa Callén; Matilde Murga; Amanda Day; Michael J Kruhlak; Nancy Wong; Meagan Munro; Arnab Ray Chaudhuri; Baktiar Karim; Bing Xia; Shunichi Takeda; Neil Johnson; Daniel Durocher; André Nussenzweig
Journal:  Mol Cell       Date:  2019-01-28       Impact factor: 17.970

10.  Identification and Characterization of MCM3 as a Kelch-like ECH-associated Protein 1 (KEAP1) Substrate.

Authors:  Kathleen M Mulvaney; Jacob P Matson; Priscila F Siesser; Tigist Y Tamir; Dennis Goldfarb; Timothy M Jacobs; Erica W Cloer; Joseph S Harrison; Cyrus Vaziri; Jeanette G Cook; Michael B Major
Journal:  J Biol Chem       Date:  2016-09-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.